Skip to the page

Data / Form D filings / AVAVA, Inc.

AVAVA, Inc.: Form D filings

AVAVA, Inc., a health care company in Waltham, MA, filed 3 Form D notices with the SEC between 2017 and 2026. The latest, on March 4, 2026, reports $19.6 million sold of a $38 million offering to 59 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
275 SECOND AVENUE FLOOR 3, Waltham, MA, 02451
Phone
(617) 912-2680
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1696341

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 4, 2026New notice$37,978,000$19,612,101$18,365,89959Feb 17, 2026sec.gov
Apr 19, 2024New notice$32,203,930$25,203,932$6,999,99841Apr 5, 2024sec.gov
Jan 30, 2017New notice$14,500,000$4,000,000$10,500,0002Jan 9, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Clinton Earl Carnell Jr.Executive Officer, Director
Mary FisherDirector
Daniel BrowneDirector
Richard Rox AndersonDirector
Jay BhawalkarExecutive Officer

Other health care companies in Massachusetts that filed recently

Every Form D from the week of Mar 2, 2026 · All recent filings in Massachusetts · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what AVAVA, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.